FI793847A - Foerfarande foer framstaellning av nya 2-substituerade 19-nor-steroidderivat - Google Patents

Foerfarande foer framstaellning av nya 2-substituerade 19-nor-steroidderivat

Info

Publication number
FI793847A
FI793847A FI793847A FI793847A FI793847A FI 793847 A FI793847 A FI 793847A FI 793847 A FI793847 A FI 793847A FI 793847 A FI793847 A FI 793847A FI 793847 A FI793847 A FI 793847A
Authority
FI
Finland
Prior art keywords
framework
steroidderivat
substitutes
Prior art date
Application number
FI793847A
Other languages
English (en)
Other versions
FI70027B (fi
FI70027C (fi
Inventor
Lucien Nedelec
Vesperto Torelli
Robert Fournex
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of FI793847A publication Critical patent/FI793847A/fi
Publication of FI70027B publication Critical patent/FI70027B/fi
Application granted granted Critical
Publication of FI70027C publication Critical patent/FI70027C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/006—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
FI793847A 1978-12-13 1979-12-10 Foerfarande foer framstaellning av terapeutiskt anvaendbara 1819-dinorpregn-4-en-3,20-dioner FI70027C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7835046 1978-12-13
FR7835046A FR2444047A1 (fr) 1978-12-13 1978-12-13 Nouveaux derives 2,2-dimethyl 19-nor steroides, leur procede de preparation et leur application comme medicaments

Publications (3)

Publication Number Publication Date
FI793847A true FI793847A (fi) 1980-06-14
FI70027B FI70027B (fi) 1986-01-31
FI70027C FI70027C (fi) 1986-09-12

Family

ID=9216044

Family Applications (1)

Application Number Title Priority Date Filing Date
FI793847A FI70027C (fi) 1978-12-13 1979-12-10 Foerfarande foer framstaellning av terapeutiskt anvaendbara 1819-dinorpregn-4-en-3,20-dioner

Country Status (14)

Country Link
US (1) US4263290A (fi)
EP (2) EP0012641B1 (fi)
JP (1) JPS5585598A (fi)
AU (1) AU527582B2 (fi)
CA (1) CA1146531A (fi)
DK (1) DK527379A (fi)
ES (1) ES486791A0 (fi)
FI (1) FI70027C (fi)
FR (1) FR2444047A1 (fi)
HU (1) HU180931B (fi)
IE (1) IE49235B1 (fi)
PT (1) PT70575A (fi)
SU (1) SU1178325A3 (fi)
ZA (1) ZA796194B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994012523A1 (en) * 1992-11-30 1994-06-09 Mallinckrodt Medical, Inc. Steroid-21-phosphate complex of technetium-99m
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
FR2917975B1 (fr) * 2007-06-26 2009-10-16 Ceva Sante Animale Sa Compositions et traitement de l'insuffisance cardiaque chez les animaux mammiferes non humains
US20090270356A1 (en) * 2008-04-28 2009-10-29 Ceva Sante Animale Sa Compositions and treatments of heart failure in non-human mammal animals
CA2813433C (en) 2010-10-27 2019-08-20 Dignity Health Trimegestone (tmg) for treatment of preterm birth

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138460A (en) * 1965-06-01 1969-01-01 Merck & Co Inc Steroid compounds
FR1476572A (fr) * 1965-09-13 1967-04-14 Gonènes synthétiques et leur procédé de préparation
FR2322606A1 (fr) * 1975-09-02 1977-04-01 Roussel Uclaf Nouveaux 2,2-dimethyl steroides, leur procede de preparation et leur application comme medicament
FR2364655A1 (fr) * 1976-09-17 1978-04-14 Roussel Uclaf Nouveaux 2,2-dimethyl 19-nor steroides, leur procede de preparation et leur application comme medicament

Also Published As

Publication number Publication date
EP0044575A1 (fr) 1982-01-27
AU527582B2 (en) 1983-03-10
AU5376279A (en) 1980-07-10
ZA796194B (en) 1980-11-26
EP0012641A2 (fr) 1980-06-25
ES8102149A1 (es) 1980-12-16
DK527379A (da) 1980-06-14
FI70027B (fi) 1986-01-31
EP0012641A3 (en) 1980-09-17
US4263290A (en) 1981-04-21
ES486791A0 (es) 1980-12-16
JPS6337796B2 (fi) 1988-07-27
FR2444047B1 (fi) 1982-05-28
EP0012641B1 (fr) 1982-05-12
IE792420L (en) 1980-06-13
SU1178325A3 (ru) 1985-09-07
PT70575A (fr) 1980-01-01
FR2444047A1 (fr) 1980-07-11
CA1146531A (fr) 1983-05-17
EP0044575B1 (fr) 1984-03-21
FI70027C (fi) 1986-09-12
JPS5585598A (en) 1980-06-27
HU180931B (en) 1983-05-30
IE49235B1 (en) 1985-09-04

Similar Documents

Publication Publication Date Title
FI790321A (fi) Foerfarande foer framstaellning av 6-substituerade tia-azafoereningar
FI791678A (fi) Foerfarande foer framstaellning av nya kefalosporinantibiotika
FI792082A (fi) Framstaellning av nya fenetanolaminer
FI801600A (fi) Foerfarande foer framstaellning av pyrimidinfoereningar
FI791679A (fi) Foerfarande foer framstaellning av nya kefalosporinantibiotika
SE437515B (sv) Forfarande for framstellning av nya fenyletylaminer
FI790584A (fi) Nya antigenderivat och foerfarande foer framstaellning av desamma
FI792207A (fi) Anordning foer snabb avskiljning av valsarna i en kalander
FI792080A (fi) Framstaellning av nya fenetanolaminer
FI803547L (fi) Foerfaranden foer framstaellning av nya piperidylbensimidazolinoner
FI782481A (fi) Foerfarande foer framstaellning av nya organiska foereningar
FI784040A (fi) Foerfarande foer framstaellning av fibervals
FI792079A (fi) Processer foer framstaellning av nya fenetanolaminer
FI791158A (fi) Foerfarande foer framstaellning av nya merkaptoimidazolderivat
FI802408A (fi) Foerfarande foer framstaellning av substituerade tetra-azatricyclen
FI65794B (fi) Foerfarande foer framstaellning av bindemedel foer haeftlim
SE7614264L (sv) Forfarande for framstellning av nya 17-estrar av 17alfa-hydroxigestogener
FI791753A (fi) Anordning foer styrning av raelsfordon i dragkoppling
NO792651L (no) Fremgangsmaate for fremstilling av spesielle steroider
FI792220A (fi) Foerfarande foer framstaellning av pyrimidinfoereningar
FI781779A (fi) Foerfarande foer framstaellning av nya nitroso-urinaemnen
FI790820A (fi) Foerfarande foer framstaellning av nya n-fenylalaninderivat
FI792706A (fi) Anordning foer gjutning av betongvaeggar
FI773846A (fi) Foerfarande foer framstaellning av nya sulfamoylbentsoesyror
FI793847A (fi) Foerfarande foer framstaellning av nya 2-substituerade 19-nor-steroidderivat

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: ROUSSEL UCLAF SOCIETE ANONYME